Methods for determining susceptibility to developmental...

Details Methods for determining susceptibility to developmental... Methods for determining susceptibility to developmental...

2005-06-23

2011-10-25

Smith, Carolyn L. (Department: 1631)

Data processing: structural design, modeling, simulation, and em

Modeling by mathematical expression

C702S020000, C702S019000, C435S006120

Reexamination Certificate

active

08046198

ABSTRACT:
The present invention discloses a novel method for identifying an individual who may be susceptible to develop a developmental disorder. In one particular example, an individual is identified who is genetically susceptible to becoming schizophrenic. In addition, the present invention discloses a novel method for identifying individuals who are genetically susceptible to have offspring with a developmental disorder. Methods of diagnosing, preventing and treating developmental disorders such as schizophrenia are also provided.

REFERENCES:
patent: 6210950 (2001-04-01), Johnson et al.
patent: 6218120 (2001-04-01), Rozen et al.
patent: 6274564 (2001-08-01), Sarill et al.
patent: 2005/0197285 (2005-09-01), Rosen et al.
patent: 2007/0031853 (2007-02-01), Stanton et al.
patent: 90/02203 (1990-03-01), None
patent: 99/01560 (1999-01-01), None
patent: 00/04194 (2000-01-01), None
Metz J, Am J Hematol (Apr. 1995);48(4):251-5.
Molloy AM, Lancet (May 31, 1997);349(9065):1591-3.
Morita H, Circulation (Apr. 15, 1997)95(8):2032-6.
Naurath HJ, Lancet(Jul. 8, 1995);346(8967):85-9.
O'Callaghan E, Br J Psychiatry(Jun. 1991); 158:764-9.
Owen MJ, Psychol Med May 1992;22(2)289-93.
Pauls DL, Adv Neurol 1992;58:151-7.
Pyper CM.box-solid. Eur J Contracept Reprod Health Care Jun. 1997;2(2):131-46.
Regland B, J Neural Transm Gen Sect 1994;98(2):143-52.
Reynolds EH, Lancet Jul. 28, 1984;2(8396):196-8.
Sanders TA, Reddy S, Am J Clin Nutr May 1994;59(5 Suppl):1176S-1181S.
Scholl TO, Am J Clin Nutr Apr. 1996;63(4):520-5.
Schorah CJ, Wild J, Lancet May 29, 1993;341 (8857):1417.
Shapiro RM, Schizophr Res Oct. 1993;10(3):187-239.
Shen F, Biochemistry Feb. 8, 1994;33(5):1209-15.
Sherrington R, Nature Nov. 10, 1988;336(6195):164-7.
Shevell MI, Rosenblatt DS, Can J Neurol Sci Nov. 1992;19(4):472-86.
Spielman RS, Am J Hum Genet Mar. 1993;52(3):506-16.
Susser E, Arch Gen Psychiatry Jan. 1996;53(1):25-31.
Susser ES, Lin SP, Arch Gen Psychiatry Dec. 1992;49(12):983-8.
Terwilliger JD, Ott J, Hum Hered 1992;42(6):337-46.
Torrey EF, Bowler A, Schizophr Bull 1990;16(4):591-604.
Torrey EF, Schizophr Bull 1993;19(3):557-62.
Trakatellis A, Postgrad Med J Oct. 1997;73(864):617-22.
van der Put NM, Lancet Oct. 21, 1995;346(8982):1070-1.
Weiffenbach B, Genomics May 1991;10(1):173-85.
Weinberg CR, Wilcox AJ, Lie RT.box-solid. Am J Hum Genet Apr. 1998;62(4):969-78.
Weinberger DR, Arch Gen Psychiatry Jul. 1987;44(7):660-9.
Whitehead AS, QJM Nov. 1995;88(11):763-6.
Wilcox AJ, Am J Epidemiol Nov. 1, 1998;148(9):893-901.
Wilcox AJ, Hum Reprod Feb. 1998;13(2):394-7.
Wouters MG, Feltil Steril Nov. 1993;60(5):820-5.
Yang JK, J Mol Biol Jun. 25, 1984;176(2):169-87.
Arinami et al., American Journal of Medical Genetics, 74:526-528 (1997).
Brown et al., Journal of Nervous and Mental Disease, 184:71-85 (1996).
Chen et al., Journal of Biological Chemistry, 259:3933-3943 (1984).
Lewis et al., Annals of Pharmacotherapy, 32:1087-1095 (1998).
Pauling, Journal of Nutritional & Environmental Medicine, 5:187-198 (1995).
Naurath et al., Lancet (North American Edition), 346:85-89 (1995).
Regland et al., J. Neural Transm, 104:931-941 (1997).
Database EMBL ′Online? Acc. nb. AA744384, Jan. 19, 1998 abstract only.
Noe et al., The Journal of Biological Chemistry, 274:27807-27814 (1999).
Noe et al., Abstract for the Animal Meeting of the RNA Society, 2000, Dept. of Biochemistry, School of Pharmacy, University of Barcelona and Dept. of Biological Sciences, Columbia University (2000).
Christensen et al. Genetic polymorphisms in methyltetrahydrofolate reductase and methionine synthase, filate levels in red blood cells, andrisk of neural tube defects. Am. J. Medical Genetics (May 21, 1999) vol. 84 (2), pp. 151-157.
Wilson et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Molecular Genetics and Metabolism (Aug. 1999) vol. 67 (4), pp. 317-323.
Maggio et al. Effects of methylfolate in the treatemtn of heterozygous beta-thalassemia patients. Current Therapeutic Research. 1994. vol. 55, No. 12, pp. 1471-1476, abstract only.
Steen et al. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenatal Diagnosis. 1998. vol. 18, No. 6, pp. 545-555.
Allen LH, Am J Clin Nutr (Nov. 1995);62(5):1013-9.
Anderson JL, J Am Coll Cardiol(Nov. 1997);30(5):1206-11.
Andreasen NC, Science(Oct. 14, 1994),266(5183):294-8.
Baird DD, Hum Reprod(Dec. 1997)12(12):2607-13.
Baron M, Acta Psychiatr Scand (Aug. 1995);92(2):81-6.
Bassett AS, Br J Psychiatry(Sep. 1992)161:323-34.
Bates CJ, Eur J Clin Nutr (Sep. 1994)48(9):660-8.
Benjamin J, Gershon ES, Biol Psychiatry (Sep. 1, 1996)40(5):313-6.
Bogerts B, Arch Gen Psychiatiy(Aug. 1985)42(8):784-91.
Boyd JH, Schizophr Bull(1986),12(2):173-86.
Carmel R, Arch Intern Med(Nov. 1987);147(11):1995-6.
Carpenter WT Jr, Buchanan RW, N Engl J Med(Mar. 10, 1994);330(10):681-90.
Chatkupt S, Am J Med Genet(Nov. 1, 1992)44(4):508-12.
Cooper BA, Rosenblatt DS, Annu Rev Nutr (1987);7:291-320.
Detera-Wadleigh SD, Nucleic Acids Res (Aug. 11, 1989);17(15):6432.
Dohrenwend BP, Science (Feb. 21, 1992);255(5047):946-52.
Duff EM, Cooper ES, Am J Public Health (Mar. 1994)84(3):473-6.
Eaton WW, Schizophr Res(Mar. 1992);6(3):181-92.
Falk CT, Rubinstein P, Ann Hum Gene(Jul. 1987); 51 (Pt 3):227-33.
Feder JN, Nucleic Acids Res(Jul. 24, 1987); 15(14):5906.
Fermo I, Ann Intern Med(Nov. 15, 1995);123(10):747-53.
Freeman JM, N Engl J Med(Mar. 6, 1975);292(10):491-6.
Gadowsky SL, J Adolesc Health (Jun. 1995);16(6):465-74.
Gilliam TC, Genomics (Nov. 1989);5(4):940-4.
Godfrey PS, Lancet(Aug. 18, 1990);336(8712):392-5.
Gordon N, Brain Dev (Sep.-Oct. 1995);17(5):307-11.
Gottesman II, Clin Genet (Jul. 1994);46(1 Spec No):116-23.
Grant SF, Nat Genet (Oct. 1996);14(2):203-5.
Green MF, Psychiatry Res(Aug. 1994); 53(2):119-27.
Guaraldi GP, Ann Clin Psychiatiy(Jun. 1993)5(2):101-5.
Heutink P, Am J Hum Genet(Aug. 1995);57(2):465-73.
Hitzig WH, Ciba Found Symp(1978)(68):77-91.
Horie N, Cell Struct Funct(Jun. 1995):20(3):191-7.
Hornsby PP, Epidemiology(Mar. 1998);9(2):193-8.
Jeste DV, Br J Psychiatiy(Oct. 1988); 153:444-59.
Kendall RE, Kemp IW, Arch Gen Psychiatry(Oct. 1989)46(10):878-82.
Kendall RE, Adams W, Br J Psychiatry(Jun. 1991);158:758-63.
Kirch DG, Schizophr Bull (1993);19(2):355-70.
Kirke PN, Q J Med (Nov. 1993)86(11):708-8.
Kovelman JA, Scheibel AB, Biol Psychiatry(Dec. 1984);19(12):1601-21.
Lewis BA, Behav Genet (May 1993);23(3):291-7.
Li N, Biochim Biophys Acta(Oct. 18, 1994);1219(2):515-20.
Lombroso PJ, J Am Acad Child Adolesc Psychiatry (Sep. 1994);33(7):921-38.
Louis-Ferdinand RT, Adverse Drug React Toxicol Rev (1994 Winter);13(4):193-206.
McPartlin J. Lancet(Jan. 16, 1993); 341(8838):148-9.
Mednick SA, Arch Gen Psychiatry (Feb. 1988);45(2):189-92.

Affiliated with

Also associated with

Rating

Methods for determining susceptibility to developmental... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for determining susceptibility to developmental..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for determining susceptibility to developmental... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4254713